Debt to Equity Ratio Analysis of Eagle Pharmaceuticals Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY Debt to Equity
Period Ending - Dec-22
Excellent Debt to Equity
0.267
Period Ending - Dec-21
Excellent Debt to Equity
0.145
Growth
84.30 %
Most recent Quarter Debt to Equity
Period Ending - Jun-23
Excellent Debt to Equity
0.278
Debt to Equity Analysis of Eagle Pharmaceuticals Inc
| Debt to Equity Ratio 0.267 of Eagle Pharmaceuticals Inc indicates to run a business company uses lower amount of long-term debt. |
| Debt to Equity Ratio of EGRX rose handsomely by 84.30 % this year. |
| Debt to Equity Ratio with value of 0.276 was highest in Year Dec-18 in last Five Years. |
| Debt to Equity Ratio with value of 0.145 was lowest in Year Dec-21 in last Five Years. |
| Latest Debt to Equity Ratio with value of 0.267 is Greater than Average Debt to Equity of 0.216 in last five years. |
Other Debt to Equity Related Info of EGRX that may interest you.
Eagle Pharmaceuticals Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| EGRX | 3.47 | 3.425 | 1.31 % | Drug Manufacturers-Specialty & Generic |
Defination of Debt to Equity Ratio
Debt to Equity Ratio shows the relationship between the company's total debt and total shareholders fund. And it indicates the ability of a company's shareholders' equity to pay its debt obligations in a tough time. more ..
Debt to Equity Related Ratios
| ShortTermDebtToEquityRatio | DividendCoverageRatio | CurrentRatio |
Tsr Stability Index
| Good Stability | |
FY - Historical Debt to Equity Ratio of Eagle Pharmaceuticals Inc
| Period | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|
| Debt to Equity | 0.267 | 0.145 | 0.178 | 0.215 | 0.276 | 0.267 | 0 |
| Change | 84.30 % | -18.53 % | -17.22 % | -22.09 % | 3.56 % | 0 % |
FY Chart of Debt to Equity Ratio of Eagle Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)